TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: A randomized controlled trial

Hepatology

Volumn 35, Issue 2, 2002, Pages 385-392

  Escorsell, Àngels ^a,d   Bañares, Rafael ^b   García Pagán, Juan Carlos ^a,d   Gilabert, Rosa ^c,d   Moitinho, Eduardo ^a,d   Piqueras, Belén ^b   Bru, Concepció ^c,d   Echenagusia, Antonio ^b   Granados, Alicia ^e   Bosch, Jaume ^a,d  

^a Liver Unit   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e GENERALITAT DE CATALUNYA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE; PROPRANOLOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG MIXTURE; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HEALTH CARE COST; HEPATIC ENCEPHALOPATHY; HIGH RISK PATIENT; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SPAIN; SURVIVAL; TREATMENT OUTCOME;

EID: 18244380855     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.30418     Document Type: Article

References (40)

1. Transjugular intrahepatic portocaval stent shunt: Preliminary clinical results
2. TIPS: The first decade
3. The transjugular intrahepatic portosystemic stentshunt procedure for variceal bleeding
4. Clinical events following TIPS: Correlation with hemodynamic findings
5. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage
6. Transjugular intrahepatic portosystemic shunt compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial
7. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial
8. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trial
9. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage
10. A randomized trial comparing Transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices
11. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding
12. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for rebleeding
13. TIPS vs sclerotherapy + propranolol in the prevention of variceal rebleeding: Preliminary results of a multicenter randomized trial
14. Transjugular intrahepatic portosystemic stent shunt versus endoscopic banding in the prevention of variceal rebleeding: Interim analysis of a randomized study
15. TIPS vs endoscopic variceal ligation in the prevention of variceal rebleeding in cirrhotic patients: A comparative randomized clinical trial (a final report)
16. TIPS for prevention of variceal bleeding in patients with cirrhosis: Meta-analysis of randomized clinical trials
17. TIPS in the prevention of variceal rebleeding. Results of randomized controlled trials (RCT)
18. TIPS: Short and long-term results: A survey of 1750 patients
19. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis
20. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: Incidence and risk factors
21. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled study
22. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors
23. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement
24. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: Results in 90 patients
25. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts
26. Baveno II consensus statements: Drug therapy for portal hypertension
27. Portal hypertension and variceal bleeding: An AASLD single topic symposium
28. Pharmacological treatment of portal hypertension: An evidence-based approach
29. Nadolol plus isosorbide-5-mononitrate compared with sclerotherapy for the prevention of variceal bleeding
30. A randomized trial comparing endoscopic ligation with nadolol plus isosorbide-5-mononitrate for the prevention of variceal rebleeding. Preliminary results
31. RCT of variceal ligation vs propranolol-isosorbide for variceal rebleeding with target pressure reduction: Methodological problems
32. The clinical evaluation of chemotherapeutic agents against cancer
33. Generic and disease-specific measures in assessing health status and HQL
34. Factors associated with poor health-related quality of life of patients with cirrhosis
35. The treatment of portal hypertension: A meta-analytic review
36. Economic considerations for the hepatologist
37. Relation between portal pressure response to pharmacological therapy and risk of recurrent variceal hemorrhage in patients with cirrhosis
38. Hemodynamic events in a prospective randomized trial of propranolol vs placebo in the prevention of a first variceal hemorrhage
39. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: A 10-year prospective study